Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization.
R. Arranz(Hospital Universitario de La Princesa), J M Fernández-Rañada(Hospital Universitario de La Princesa), Rafael Carrión, Miguel Ángel Lozano, José I. López(BioCruces Health research Institute), P. Zamora, Rámón Colomer(Hospital Universitario de La Princesa), M González Barón, G. Pérez-Manga, Guillermo J. Pérez(Universitat de Girona), Eduardo Flores‐Villalba, José García‐Laraña, Pilar García‐Alfonso(Hospital General Universitario Gregorio Marañón), Esperanza Lavilla, C Rayón, Paz Sobrino‐Vegas
Cited by 56
Related Papers
Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer
|New England Journal of Medicine|2019|1.5k